Yicura BioMed
Yicura BioMed closes first tranche of Series B led by Gobi Partners
Hong Kong clinical-stage biotech Yicura BioMed has completed the first closing of a Series B led by Gobi Partners, with the amount undisclosed.
Hong Kong clinical-stage biotech Yicura BioMed has completed the first closing of a Series B led by Gobi Partners, with the amount undisclosed.
